Back
Invesco Russell 1000Dynmc-MltfctrETFCADH Vs. NovoCure Industry Stock Comparison
Buy
86
IUMF.F.TO
Invesco Russell 1000Dynmc-MltfctrETFCADH
Last Price:
22.14
Seasonality Move:
7.2%
Buy
75
NVCR
NovoCure
Last Price:
33.40
Seasonality Move:
-5.24%
Buy
86
Invesco Russell 1000Dynmc-MltfctrETFCADH (IUMF.F.TO)
is a Buy
Is Invesco Russell 1000Dynmc-MltfctrETFCADH a Buy, Sell or Hold?
- The current Invesco Russell 1000Dynmc-MltfctrETFCADH [IUMF.F.TO] share price is $22.14. The Score for IUMF.F.TO is 86, which is 72% above its historic median score of 50, and infers lower risk than normal.
- IUMF.F.TO is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
75
NovoCure (NVCR)
is a Buy
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $33.41. The Score for NVCR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IUMF.F.TO Stock Price Chart
What is Invesco Russell 1000Dynmc-MltfctrETFCADH's stock price today?
-
The Invesco Russell 1000Dynmc-MltfctrETFCADH share price today is $22.14
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IUMF.F.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.
IUMF.F.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.21 | Buy |
| Relative Strength Index (14 RSI): | 63.99 | Buy |
| Chaikin Money Flow: | 2500 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.48 - 22.06) | Buy |
| Bollinger Bands (100): | (20.01 - 21.59) | Buy |
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.78 | Buy |
| Relative Strength Index (14 RSI): | 75.34 | Buy |
| Chaikin Money Flow: | 1118573 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.36 - 28.56) | Buy |
| Bollinger Bands (100): | (14.7 - 22.78) | Buy |
IUMF.F.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.1 | Buy |
| 20-day SMA: | 21.8 | Buy |
| 50-day SMA: | 21.43 | Buy |
| 200-day SMA: | 20.89 | Buy |
| 8-day EMA: | 22.05 | Buy |
| 20-day EMA: | 21.86 | Buy |
| 50-day EMA: | 21.48 | Buy |
| 200-day EMA: | 20.71 | Buy |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.6 | Buy |
| 20-day SMA: | 23.68 | Buy |
| 50-day SMA: | 19.33 | Buy |
| 200-day SMA: | 17.9 | Buy |
| 8-day EMA: | 29.53 | Buy |
| 20-day EMA: | 25.45 | Buy |
| 50-day EMA: | 21.38 | Buy |
| 200-day EMA: | 19.88 | Buy |
Invesco Russell 1000Dynmc-MltfctrETFCADH Earnings Growth & IUMF.F.TO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.31 per share.
Invesco Russell 1000Dynmc-MltfctrETFCADH Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovoCure Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||